Personalized gene expression profiling-guided (MAGE) therapy in resistant sarcomas. Preliminary data. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback